TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.10$ -1.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Metagenomi, Inc. (MGX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.5% of the shares are freely tradable; institutional investors hold 19.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 19.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 19.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 67.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 38Mio.

Largest Shareholders

Institutions

Institutions MGX
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 2.80 1,057,944 +0.0 03/31/2026
Renaissance Technologies Corp 2.09 787,900 +25.4 03/31/2026
Catalio Capital Management, LP 1.40 528,993 +0.0 06/30/2026
Peapod Lane Capital LLC 1.39 525,024 +1.6 06/30/2026
Two Sigma Investments LLC 1.36 513,701 +3.4 06/30/2026
Bridgeway Capital Management, LLC 1.05 395,800 +0.0 03/31/2026
Jacobs Levy Equity Management, Inc. 1.01 382,153 +0.0 03/31/2026
Geode Capital Management, LLC 0.95 358,200 +17.1 03/31/2026

Funds

Funds MGX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.96 741,407 +0.0 07/31/2026
Bridgeway Ultra-Small Company 0.87 327,100 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings MGX
Person Role Shares Value As of Type
Irish Jian See Remarks 375,393 412,932 $ Sep 8, 2026 direct
Wapnick Pamela Chief Financial Officer 206,580 227,238 $ Sep 8, 2026 direct
Wein Matthew See Remarks 126,133 138,746 $ Sep 8, 2026 direct
Reid Laurence Director 20,000 22,000 $ Sep 9, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 9, 2026 Reid Laurence Director Buy 117 1.18 138
Sep 9, 2026 Reid Laurence Director Buy 19,883 1.17 23,263
Sep 8, 2026 Wein Matthew See Remarks Sell 358 1.16 415
Sep 8, 2026 Irish Jian See Remarks Sell 2,140 1.16 2,479
Sep 8, 2026 Wapnick Pamela Chief Financial Officer Sell 1,911 1.16 2,214

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?